Kelli A Lovelace MD

Physician

2121 E 21st StTulsa, OK 74114
Phone+1 918-749-2261

Dr. Lovelace is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lovelace's full profile Already have an account?

Education & Training

University of Oklahoma Health Sciences CenterResidency, Dermatology, 2004 - 2007
University of Oklahoma College of MedicineInternship, Transitional Year, 2003 - 2004
University of Oklahoma College of MedicineClass of 2003

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OK State Medical License 2004 - 2027
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EMA, Modernizing Medicine, Inc., 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification EMA Mobile, Modernizing Medicine, Inc., 2012, 2014-2017
CMS Meaningful Use Stage 2 Certification EMA, Modernizing Medicine, Inc., 2012, 2014-2017

Publications & Presentations

PubMed

37 citations
Malignant proliferating pilar tumors arising in KID syndrome: a report of two patients.
Gurston Nyquist, Christina Mumm, Renee H. Grau, A. Neil Crowson, Daniel L. Shurman
American Journal of Medical Genetics. Part A. 2007-04-01
27 citations
Etanercept and the treatment of multicentric reticulohistiocytosis.
Kelli Lovelace, Aaron Loyd, David M. Adelson, Neil Crowson, J. R. Taylor
Archives of Dermatology. 2005-09-01